Effects of trauma and infection on ciprofloxacin levels in the vitreous cavity

Retina

Volumn 19, Issue 2, 1999, Pages 127-130

  Öztürk, Faruk ^a,c   Kortunay, Selim ^b   Kurt, Emin ^a   Ilker, S Sami ^a   Inan, Ü Übeyt ^a   Basci, Nursabah E ^b   Bozkurt, Atila ^b   Kayaalp, S Oǧuz ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c MH Merkez Efendi State Hospital   (Turkey)

Author keywords

Ciprofloxacin; Endophthalmitis; Intravitreal injection; Pharmacokinetics; Trauma

Indexed keywords

CIPROFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG TISSUE LEVEL; EYE INFECTION; EYE INJURY; NONHUMAN; RABBIT; STAPHYLOCOCCUS AUREUS; VITREOUS DISEASE;

EID: 0343674494     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-199902000-00007     Document Type: Article

References (20)

1. Neu HC. Microbiologic aspects of fluoroquinolones. Am J Ophthalmol 1991;112:15S-24S.
2. Alfaro DV, Roth D, Lignett PE. Posttraumatic endophthalmitis: causative organisms, treatment, and prevention. Retina 1994;14:206-211.
3. Lesk MR, Ammann H, Marcil G, et al. The penetrating of oral ciprofloxacin into the aqueous humor, vitreous and subretinal fluid of humans. Am J Ophthalmol 1993;115:623-628.
4. Kowalski RP, Karenchak LM, Eller EW. The role of ciprofloxacin in endophthalmitis therapy. Am J Ophthalmol 1993; 116:695-699.
5. Pearson PA, Hainsworth DP, Ashton P. Clearance and distribution of ciprofloxacin after intravitreal injection. Retina 1993; 13:326-330.
6. Kim SH, Kim JH, Chu KS, Kwak JS. Safety of intravitreally injected ciprofloxacin in phakic rabbit eyes. Korean J Ophthalmol 1995;9:12-18.
7. Stevens SX, Fouraker BD, Jensen HG. Intraocular safety of ciprofloxacin. Arch Ophthalmol 1991;109:1737-1743.
8. Rootman DS, Savage P, Hasany SM, et al. Toxicity and pharmacokinetics of intravitreally injected ciprofloxacin in rabbit eyes. Can J Ophthalmol 1992;16:277-282.
9. Cobo LC, Forster RK. The clearance of intravitreal gentamicin. Am J Ophthalmol 1981;92:59-62.
10. Kane A, Barza M, Baum J. Intravitreal injection of gentamicin in rabbits: effect of inflammation and pigmentation on half-life and ocular distribution. Invest Ophthalmol Vis Sci 1981;20:593-597.
11. Picker L, Meredith TA, Gardner S, Wilson LA. Cefazolin levels after intravitreal injection: effects of inflammation and surgery. Invest Ophthalmol Vis Sci 1990;31:502-505.
12. Mandell BA, Meredith TA, Aguilar E, et al. Effect of inflammation and surgery on amikacin levels in the vitreous cavity. Am J Ophthalmol 1993;115:770-774.
13. Barza M, Lynch E, Baum JL. Pharmacokinetics of newer cephalosporins after subconjunctival and intravitreal injection in rabbits. Arch Ophthalmol 1993;111:121-125.
14. Shaarawy A, Meredith TA, Kincaid M, et al. Intraocular injection of ceftazidime: effects of inflammation and surgery. Retina 1995;15:433-438.
15. Aguilar HE, Meredith TA, El-Massry A, et al. Vancomycin levels after intravitreal injection: effects of inflammation and surgery. Retina 1995;15:428-432.
16. Alfaro DV, Runyan T, Kirkman E, et al. Intravenous cefazolin in penetrating eye injuries: treatment of posttraumatic endophthalmitis. Retina 1993;12:331-334.
17. Peyman GA, Pague JT, Meihels HI, Bennett TO. Postoperative endophthalmitis: a comparison of methods for treatment and prophylaxis with gentamicin. Ophthalmic Surg 1975;6:45-55.
18. Basel NE, Bozkurt A, Kalaycl D, Kayaalp SO. Rapid liquid chromatographic assay of ciprofloxacin in human aqueous humor. J Pharm Biomed Anal 1996;14:353-356.
19. Barza M, Kane A, Baum J. Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys. Invest Ophthalmol Vis Sci 1983;24:1602-1606.
20. Cormican MG, Jones RN. Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococci. Drugs 1996;51 (Suppl 1):6-12.